ZYUS Life Sciences is a Saskatchewan-based company focused on cannabinoid-derived pharmaceutical drug candidates and medical cannabinoid products. Public materials describe a strategy that combines clinical development, regulatory approval, and direct patient access, especially in pain management and related indications. The company also highlights GMP-compliant cannabinoid formulations and international distribution of medical cannabinoid products.